Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Drug Information » FDA Approved Drugs » 1997
Medical Areas: Endocrinology | Psychiatry/Psychology | Family Medicine

View By:YearCompanyConditionsTherapeutic AreasDrug Names

Trazadone 150mg

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Teva Pharmaceutical
Approval Status: Approved May 1997
Treatment Area: depression

General Information

Trazadone 150mg tablets have been approved to manufacture and market as a treatment for depression. Teva previously received approval for 50mg and 100mg dosage strengths. Trazadone is the generic equivalent of Bristol Meyers Squibb’s Desyrel 7.